Mayne Pharma Group Limited
MAYNF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $416,467 | $370,120 | $316,940 | $18,595 |
| - Cash | $59,839 | $110,068 | $101,714 | $96,672 |
| + Debt | $41,271 | $70,462 | $47,505 | $413,666 |
| Enterprise Value | $397,899 | $330,514 | $262,731 | $335,589 |
| Revenue | $408,095 | $388,151 | $183,586 | $157,147 |
| % Growth | 5.1% | 111.4% | 16.8% | – |
| Gross Profit | $247,274 | $218,527 | $26,838 | $170,146 |
| % Margin | 60.6% | 56.3% | 14.6% | 108.3% |
| EBITDA | $42,078 | -$87,127 | -$174,409 | -$46,340 |
| % Margin | 10.3% | -22.4% | -95% | -29.5% |
| Net Income | -$93,836 | -$174,233 | $117,249 | -$209,481 |
| % Margin | -23% | -44.9% | 63.9% | -133.3% |
| EPS Diluted | -1.14 | -2.12 | -3.67 | -3.2 |
| % Growth | 46.2% | 42.2% | -14.7% | – |
| Operating Cash Flow | $17,469 | -$15,300 | -$43,123 | -$16,618 |
| Capital Expenditures | -$12,276 | -$20,862 | -$219,585 | -$11,853 |
| Free Cash Flow | $5,193 | -$36,162 | -$262,708 | -$28,471 |